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Snl'ltlmal~ 
Tolerance to bacterial lipopolysaccharide (LPS, endotoxin) is an adaptive cellular process whereby 
exposure to endotoxin induces a subsequent hyporesponsive state characterized by decreased levels 
of LPS-induced cytokine mRNA and protein.  We demonstrate, in a human promonocytic cell 
line,  THP-1, that endotoxin tolerance is manifested by decreased LPS-induced interleukin  1 3 
(IL-13) transcription.  Inhibition of protein synthesis reverses the tolerant phenotype by inducing 
transcription  of IL-13 in the absence of a second stimulus.  These results indicate that  a labile 
protein contributes to the endotoxin-tolerant phenotype, and that this factor acts in a dominant 
repressive manner  to inhibit  the activity of existing transcription  factors.  We provide further 
data that cellular expression of IKB-o~ correlates with downregulated IL-13 gene expression during 
endotoxin tolerance, implicating IKB-o~ as a potential candidate for the labile repressor identified 
herein. 
C 
ells exposed to endotoxin become refractory to further 
challenge with this agent. This phenomenon of endo- 
toxin tolerance was first demonstrated in animal models of 
endotoxemia (1), and can be induced in a variety of primary 
monocyte/macrophage cells and cell lines (2-6). In humans, 
this condition is observed in the PBMC isolated from sub- 
jects given a single intravenous dose of Escherichia coli endo- 
toxin (7), and in the neutrophils and monocytes isolated from 
patients in septic shock (8, 9). The endotoxin-tolerant  state 
is characterized by decreased cytokine production after a chal- 
lenge dose of LPS,  as compared with  those levels induced 
by an initial dose. Adaptation to stimulation by bacterial en- 
dotoxin perhaps evolved as a mechanism to curb the infected 
hosts' continuous response to the invading organism, and to 
reduce the potentially lethal autotoxic effects precipitated by 
overproduction of inflammatory mediators such as IL-1 and 
TNF-ot. 
The molecular events that regulate endotoxin tolerance are 
unclear but result in repressed expression of cytokine genes 
(2-5), and altered cytokine processing and secretion (6). We 
previously reported that  neutrophils  isolated from patients 
in septic shock are consistently tolerant to LPS-induced IL-13 
mRNA and protein synthesis (8). To further study the mo- 
lecular basis of endotoxin tolerance in human leukocytes, we 
developed an in vitro model of tolerance in the human pro- 
monocytic cell line,  THP-1.  Here we report that,  as with 
the human  neutrophil,  endotoxin-tolerant  THP-1 cells ex- 
hibit reduced levels of LPS-induced steady state IL-13 mRNA. 
Downregulation of gene expression is at the level of IL-13 
gene transcription,  and appears to be mediated by the syn- 
thesis of a labile dominant  transcriptional  repressor. 
Materials and Methods 
Cell Culture and Induction of Endotoxin Tolerance.  THP-1 cells 
were obtained from the American Type Culture Collection (ATCC, 
Rockville, MD) and maintained at 37~  5% CO2 in RPMI-1640 
media supplemented with 10 U/ml penicillin G, 10/zg/ml strep- 
tomycin, 2 mM t-glutamine,  and 10% fetal bovine serum (FBS)  1 
(Hyclone Laboratories, Logan, UT). Cells were cultured to a den- 
sity of 5.0  x  10  s cells/ml, and passaged with a 1:3 ratio split. Un- 
less otherwise indicated in the figure legend, endotoxin tolerance 
was induced by suspending the cells in RPMI-1640 supplemented 
with 10 U/m1 penicillin G, 10 #g/ml streptomycin, 2 mM L-glu- 
tamine, and 2% FBS at a density of 106 cells/ml and treating them 
with 1 #g/ml LPS (E. coli 0111:B4; Sigma Chemical Co., St. Louis, 
MO) for 16 h. The cells were then pelleted, washed once in PBS, 
resuspended in media at 1@ cells/m1, and stimulated as described 
in the figure legends. For all assays, control cells were treated simi- 
larly, but were not given the primary  LPS dose. 
Monocyte Isolation and Induction of Endotoxin Tolerance.  Human 
PBMC were isolated from heparinized venous blood obtained from 
normal  adult volunteers by plasma gel (Cellular Products,  Inc., 
Buffalo, NY)  sedimentation  and Isolymph  (Gallard-Schlesinger 
Chemical Mfg. Corp., Carle Place, NY) centrifugation.  The cells 
1 Abbreviations used in this paper: CHX, cycloheximide; FBS, fetal bovine 
serum; GAPDH, glyceraldehyde  phosphate  dehydrogenase;  NF-~B, nuclear 
factor KB. 
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penicillin G,  10 #g/ml streptomycin, and 2 mM t-glutamine  at 
a density of 106 cells/ml and enriched for monocytes by a 2-b ad- 
herence step. Fresh media, supplemented  with 10% FBS, was added, 
and the cells were incubated for 24 h in the presence or absence 
of 1 #g/ml E. coli LPS. Media was again removed, the cells washed 
once with PBS, and fresh media added. The cells were then treated 
as described in the figure legend. 
RNA Extraction and Northern Analysis.  Total  RNA was iso- 
lated using the RNazol B method (Tel-Test, Inc., Friendswood, 
TX). Routinely, 5.0  x  106 THP-1 cells/condition and 1.0  x  107 
monocytes/condition were used. Total RNA (10 #g/lane) was frac- 
tionated on a 1% agarose, 6.6% formaldehyde gel in 1X MOPS 
buffer (0.02 M 3-(N-morpholino) propanesulfonic acid, 5 mM so- 
dium acetate, and 1 mM EDTA), and capillary blotted onto nylon 
membrane falters (Gene Screen Plus; DuPont-NEN, Boston, MA). 
UV cross-linking was performed using a Stratalinker UV cross- 
linker (Stratagene, La Jolla,  CA). 
The plasmid containing a human IL-1B cDNA insert, pHulL1/ 
pGEM1 was linearized with EcoRI and labeled using a NEN Nick 
Translation System kit.  Filters were prehybridized in  5-10  ml 
QuikHyb hybridization buffer (Stratagene) for 15 min at 68~ 
in  an  Autoblot  Micro  Hybridization  Oven (Bellco Glass Inc., 
Vineland, NJ).  106 cpm probe/ml QuikHyb and  1 mg herring 
sperm DNA were added and hybridization was carried out for I h 
at 68~  The filters were washed twice for 15 min at room tem- 
perature in 2X SSC/0.1% SDS, and once for 30 min at 60~  in 
0.1X SSC/0.1% SDS. The filters  were exposed for 6-24 h to Kodak 
XAR film with two intensifying screens at  -70~ 
The filters  were stripped by boiling for 30 min in 0.1X SSC/0.1% 
SDS and reprobed, under the same conditions, with EcoRI linear- 
ized, nick-translated plasmid containing cDNA of human glycer- 
aldehyde phosphate dehydrogenase (GAPDH) (pHcGAP, ATCC). 
ILlI3 mRNA Decay Analysis.  Control and endotoxin-tolerant 
cells were treated with 1 #g/ml LPS, 10 #M cycloheximide  (CHX), 
and 10 #M CHX plus 1 #g/ml LPS for 2.5 h.  Actinomycin D 
(10 #M) was added to inhibit further transcription. Beginning 0.5 h 
after addition of actinomycin D, aliquots of cells were removed at 
1-h intervals over a 10-h time course. Total RNA was isolated, dena- 
tured in 50% formaldehyde/10X SSC, and serial dilutions were 
dot-blotted  onto Gene Screen Plus membranes. The filters were 
probed as described for Northern analysis, and exposed to film for 
various lengths of time to insure linearity of signal. The signals 
at each time point were quantitated by densitometry and expressed 
as a percentage of the signal at the first time point. 
Nuclear Run-on  Analysis.  Nuclei isolation  and  transcription 
assays were performed as described (10). Routinely,  5.0  x  107 
cells/condition were used. Equal counts of nascent transcripts were 
hybridized for 48 h to Nytran filters containing 10 #g/slot of lin- 
earized, denatured pHulL1/pGEM1 and pGEM-7 (Promega Corp., 
Madison, WI). The filters were washed twice for 15 min at room 
temperature in 2X SSC/0.1% SDS, and once for 30 min at 42~ 
in 0.1X SSC/0.1% SDS. The filters  were exposed  for 24 h to Kodak 
XAR film with two intensifying screens at - 70~  Radioactivity 
was quantitated by a Radioanalytic Imaging System (AMBIS Inc., 
San Diego,  CA) and specific hybridization  of IIA3 mRNA to 
pHull~l is expressed relative to nonspecific binding to pGEM-7 
(it was not possible to normalize to transcription of housekeeping 
genes as that of GAPDH was undetectable, and that of B-actin 
was found to vary with the experimental conditions). 
Western Analysis.  Control and endotoxin-tolerant  cells were 
treated with 1 #g/ml LPS, 10 #M CHX, and 1 #g/ml LPS plus 
10 #M CHX for the times indicated in the figure legend. The cells 
were pelleted and lysed in NP-40 lysis buffer (100 mM Tris, 100 
mM NaC1, 2 mM EDTA, 1% NP-40,  1 mM Na3VO4, 50 mM 
NaF, 0.1 mM Quercetin,  I mM PMSF, 1 #g/ml aprotinin,  and 
1 #g/ml leupeptin). Protein concentrations were determined using 
the Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL). 
100 #g protein/lane was separated  by SDS-PAGE  (10% acrylamide) 
according to the Laemmli method,  along with low-range molec- 
ular weight markers (Bio-Rad  Laboratories,  Hercules, CA) and trans- 
ferred to Hybond-enhanced chemiluminescence (ECL) nitrocellu- 
lose (Amersham Corp., Arlington Heights, IL) at 100 mA for 16 h, 
at room temperature. The nitrocellulose membrane was blocked 
for 1 h with 5% nonfat dry milk, in TBS-Tween  (20 mM Tris base, 
137 mM NaC1, and 0.1% Tween-20). The membrane was washed 
four  times  in  TBS-Tween and  incubated  for  1 h  with  rabbit 
anti-human IKB-c~  antibody (Santa Cruz Biotechnology Inc., Santa 
Cruz, CA),  diluted in 5% BSA in TBS-Tween. The membrane 
was again washed four times in TBS-Tween and incubated for 
1 h with goat anti-rabbit  IgG, conjugated to horseradish peroxi- 
dase (Organon Teknika Corp.,  Durham,  NC).  The membrane 
was washed four times in TBS-Tween  and IKB-ol  protein was visual- 
ized using Renaissance Western Blot Chemiluminescence Reagent 
(DuPont-NEN). 
Resnlts and Discussion 
Endotoxin tolerance was induced by stimulating THP-1 
cells with two consecutive doses of LPS and the conditions 
optimized by varying the concentration and the duration of 
the primary dose. Northern analysis indicated that endotoxin 
tolerance was induced by all primary dose concentrations ex- 
amined, and that the degree of tolerance became more pro- 
nounced when the primary dose was increased (Fig.  1 A). 
To assess the effects of altering the duration of the primary 
dose, THP-1 cells were incubated with the primary dose of 
LPS for increasing lengths of time before stimulation with 
the challenge dose.  Fig.  1 B illustrates that cells exposed to 
the primary dose for 10-19 h become progressively less respon- 
sive to the challenge dose.  Not shown are data indicating 
that endotoxin tolerance is observed as early as 6 h  and as 
late as 44 h after the primary stimulus. To compare the ki- 
netics of LPS-induced IL-13 mRNA accumulation in endo- 
toxin-tolerant cells relative to control cells, we treated control 
and endotoxin-tolerant THP-1 cells with LPS and measured 
IL-13 mRNA levels over a 5-h time course (Fig. 1 C). We 
found that endotoxin-tolerant cells respond more rapidly to 
LPS than do control cells,  but that the overall  response is 
diminished. 
In several models of endotoxin tolerance, downregulated 
cytokine production is specific for LPS as the challenge stimulus 
(4, 8, 11), whereas in other models, the endotoxin-tolerant 
cells are also refractory to challenge by other agents (3, 7). 
To determine whether endotoxin-tolerant THP-1 cells could 
respond normally to other stimuli, control and endotoxin- 
tolerant cells were treated with increasing concentrations of 
PMA (Fig. 2). We observed that tolerance to stimulation by 
endotoxin is coincident with an enhanced response to PMA. 
This observation suggests that the primary LPS dose induces 
enduring changes in the intracellular pathways leading to IL- 
13 gene expression. Thus, in our model, the LPS-induced 
anergy may be due to synthesis or activation of a negative 
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refractory to further stimulation with this agent.  (A) 
THP-1 cells were treated with 0, 10 ng/ml, 100 ng/ml, 
or 1/~g/ml LPS and incubated for 16 h. The cells were 
washed once in PBS and challenged with 0,  10 ng/ml, 
100 ng/ml, and 1/~g/ml LPS for 3 h. (B) THP-1 cells 
were stimulated with 1/zg/ml LPS for  10, 12, 14, 16, 
and 19 h before being washed and restimulated with 1 
/~g/ml LPS for 3 h. (C) Control and endotoxin-tolerant 
THP-1 cells were treated with 1/zg/ml LPS and RNA 
was isolated at 1-h time points over a 5-h time course. 
Expression of IblB and GAPDH mRNA was determined 
by Northern analysis. 
Figure 2.  Endotoxin-tolerant  THP-1 cells display 
an enhanced  response to PMA. Control and endotc~dn- 
tolerant cells were treated with 1/zg/ml LPS, and 0.1, 
1.0, 10, 50, and 100 ng/ml PMA for 3 h. Expression 
of IL-1/5 and GAPDH mRNA was determined  by 
Northern analysis. 
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IL-1B mRNA  accumulation  in  endotoxin-tolerant 
THP-1 cells. (/1) Control and endotoxin-tolerant cells 
were left unstimulated, or treated with 1 #g/m1 LPS, 
10/~M CHX,  and 1/,g/ml LPS plus 10/*M CHX 
for 3 h. (B) Control and endotoxin-tolerant cells were 
left umtimulated, or treated with 1/~g/ml LPS, 10 #M 
CHX,  100 ng/ml anisomycin,  10/~g/ml puromycin, 
and  10  #M  emetine for 3  h.  Expression  of IL-1B 
and GAPDH mRNA was determined by Northern 
analysis. 
factor(s) which selectively represses further LPS-induced sig- 
naling, whereas the LPS-induced priming effects are due to 
synthesis or activation of a positive factor(s) in that portion 
of the pathway shared by LPS and PMA. In support of this 
hypothesis, a similar phenomenon  has been reported by Zhang 
and Morrison (12), who observed that pretreating mouse peri- 
toneal macrophages with LPS differentially modulated their 
TNF-c~ and nitric oxide production in response to challenge 
with other stimuli. 
Regulation of IL-1/3 gene expression occurs transcription- 
ally and posttranscriptionally (13). As labile proteins have been 
implicated in the regulation of both of these processes (14, 
15), we examined whether ongoing protein synthesis was 
required to maintain the endotoxin-tolerant state. Whereas 
we had anticipated that the endotoxin-tolerant cells might 
regain their LPS responsiveness  in the absence of de novo 
protein synthesis, we observed that treating these cells with 
CHX alone results in a significant  accumulation of IL-1/3 
mRNA, while having minimal effects on the control cells 
(Fig. 3 A). To establish that the induction of IL-1/3 gene ex- 
pression by CHX results from inhibition of protein synthesis, 
and is not due to the activation, by CHX, of alternate signal 
transduction pathways,  we treated control and endotoxin- 
tolerant cells with a panel of agents known to inhibit trans- 
lation by different mechanisms (Fig.  3 B).  We found that 
control cells respond only slightly to stimulation with CHX, 
anisomycin, puromycin, and emetine, whereas the endotoxin- 
tolerant cells increase IL-1B mRNA in response to all four 
protein synthesis inhibitors. This effect is not observed at con- 
centrations of these agents that are insufficient to inhibit pro- 
tein synthesis (data not shown), but which may activate al- 
ternate signal transduction pathways in the cell (16). These 
data indicate that inhibition of de novo protein synthesis over- 
comes or reverses downregulation of IL-1/3 gene expression 
in endotoxin-tolerant THP-1 cells, and that the continuous 
synthesis of a labile protein is required for repression of LPS- 
induced IL-1/3 gene expression during endotoxin tolerance. 
The reversal of downregulated IL-1/3 mRNA synthesis by 
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htion in endotoxin-tolerant human peripheral blood monocytes.  Control 
and endotoxin-tolerant  cells were left unstimulated,  or treated with 1/~g/ml 
LPS, 10/~M CHX, and 1/~g/ml LPS plus 10/~M CHX for 3 h. Expres- 
sion of IL-1/~  and GAPDH mR.NA was determined by Northern analysis. 
inhibition of protein synthesis is not unique to the THP-1 
cell line, but also extends to human peripheral blood mono- 
cytes rendered endotoxin-tolerant in vitro.  Monocytes that 
have been preincubated with LPS for 24 h have a decreased 
Figure  5.  Inhibition of protein synthesis induces  Ibl/~ transcription 
in endotoxin-tolerant THP-1 cells. (A) Nuclear run-on analysis was per- 
formed on nuclei isolated from control and endotoxin-tolerant cells that 
were unstimulated, or treated for 2 h with 1/~g/ml LPS, 100 ng/ml PMA, 
10/~M CHX,  and 1/~g/ml LPS plus 10/~M CHX.  (B) Shown is the 
average  _+  SEM of three separate experiments. The differences observed 
between control and endotoxin-tolerant cells are statistically significant 
(/, <0.05 by nonpaired t test) in all conditions except  +CHX/LPS. 
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IL-1/3 mRNA response to a second dose of LPS, but display 
an enhanced response to treatment with CHX alone, or CHX 
plus LPS (Fig.  4). We did note that nonendotoxin-tolerant 
monocytes treated with CHX synthesize greater levels of IL-I~ 
mRNA than do CHX-treated control THP-1 ceUs, perhaps 
as a result of their more advanced state of differentiation. 
IL-1/3 belongs to a dass of rapid response genes containing 
single or multiple repeats of the consensus sequence ATTTA 
within their 3'-untranslated region. Since this AU-rich de- 
ment (ARE) is involved in regulation of transcript stability 
(17), we examined the contribution of altered IL-1/~ mRNA 
stability to endotoxin tolerance. IL-1/~ mRNA decay anal- 
ysis revealed that the half-life of LPS-induced IL-1/~ mRNA 
is "~2.5 h in both control and endotoxin-tolerant cells, indi- 
cating that the low levels of LPS-induced IL-1/3 transcripts 
in endotoxin-tolerant cells are not due to enhanced transcript 
decay. Treating the ceUs with CHX,  and CHX  plus LPS, 
was found to increase the half-life of the message, but did 
so to equivalent degrees in both control and endotoxin-tolerant 
cells (data not shown). Whereas this stabilization may be due 
to elimination of a labile regulatory protein(s),  it has been 
demonstrated that mRNA containing an ARE must be trans- 
lated to be rapidly degraded (18). In any event, we observed 
no significant differences in the regulation of IL-1/~ transcript 
stability in control versus endotoxin-tolerant THP-1  cells. 
The mRNA decay analysis indicates that the disparate levels 
of steady state IL-1/~ mRNA observed in control and endo- 
toxin-tolerant cells must be regulated predominantly at the 
level of transcript synthesis. To assess differences in IL-1/~ tran- 
scription, nuclear run-on analysis was performed on control 
and endotoxin-tolerant THP-1 cells treated with LPS, PMA, 
CHX,  and LPS plus CHX  (Fig.  5).  This analysis  revealed 
that LPS induces greater levels of IL-1B transcription in con- 
trol cells than in endotoxin-tolerant cells,  confirming that 
the decreased levels of LPS-induced steady state IL-1B mRNA 
in these cells is a consequence of  decreased transcription. Con- 
versely, PMA induces significantly greater levels of IL-1/~ tran- 
scription in endotoxin-tolerant cells than in control cells, in- 
dicating that the primed response observed previously (Fig. 
2) was at least partially due to enhanced transcription.  Whereas 
CHX induces negligible IL-1B transcription in the control 
cells, treating endotoxin-tolerant cells with this agent alone, 
or in concert with LPS,  reverses the transcriptional block. 
This observation supports our concept wherein both posi- 
tive and negative regulatory factors exist in endotoxin-tolerant 
THP-1 cells. The primary LPS dose activates  the transcrip- 
tion factors involved in upregulation of IL-1/3 gene expres- 
sion,  as  well  as  induces the synthesis of a  transcriptional 
repressor, whose activity then produces the endotoxin-tolerant 
phenotype. Treating the tolerant cells with CHX eliminates 
this dominant repressor activity by inhibiting  synthesis of 
either the factor itself or, possibly,  of another protein that 
serves to maintain its activity as a repressor (e.g.,  a kinase 
or phosphatase). This allows the existing positive factors to 
reinitiate  transcription,  even  in  the  absence  of a  second 
stimulus. 
The transcription factors that regulate LPS-induced IL-13 
gene expression have not yet been fully elucidated, although Figure 6.  Inhibition  of  protein  synthesis  results  in a decrease  in steady 
state IgB-ot  in endotoxin-tolerant  THP-1 calls. Western  analysis  was per- 
formed on cell lysates  from control  and endotoxin-tolerant  THP-1 cells 
that were  untreated,  or stimuhted  with 1 #g/ml LPS for 30 and 90 min, 
or with 10 #M CFIX and 10 #M CHX plus 1 #g/ml LPS for 30 min. 
recent evidence suggests  that  nuclear factor KB  (NF-KB), 
NF-IL6 (CCAAT/~hancer binding protein [C-EBPB]), cAMP 
response element binding protein (CREB), and other factors 
may be key participants  in the signaling pathway (19-21). 
In unstimulated cells, the transcription factor NF-KB, typi- 
cally a heterodimer composed of a 50-  and 65-kD protein 
subunit, resides in the cytoplasm associated  with an inhibi- 
tory protein subunit, IgB (22).  After stimulation with a va- 
riety of agents, including LPS, Ix]] is phosphorylated (23), 
dissociates  from NF-KB, and is rapidly degraded, allowing 
the NF-KB complex to translocate to the nucleus (24). Among 
the many genes induced by LPS is  that of IKB itself (25), 
thus providing an efficient negative feedback mechanism for 
LPS-induced/NF-KB-mediated gene expression. In view of 
its inducibility by LPS and its labile nature when dissociated 
from NF-gB (26), IKB is a potential candidate for the domi- 
nant negative activity identified in this study. To examine 
this possibility, we assayed expression of boB-or (MAD-3) by 
Western analysis and found that the presence of IKB-oL pro- 
tein does indeed correlate inversely with IL-lfl transcription 
in our system (Fig. 6). Unstimulated control and endotoxin- 
tolerant THP-1 cells contain equivalent steady state levels of 
IgB-c~, and treating both populations of cells with LPS in- 
duces IxB-c~ decay. However, IKB-ot is more rapidly regener- 
ated in the endotoxin-tolerant cells, returning to normal levels 
by 90 min after stimulation, while remaining low in the con- 
trol cells.  As IKBc~ can dissociate NF-KB from its cognate 
DNA (27),  this observation suggests that there may be only 
a transient pulse of NF-IcB activity in the endotoxin-tolerant 
cells, compared with a more sustained NF-KB-mediated signal 
in the control cells, thus accounting for the disparate levels 
of LPS-induced IL-lfl mRNA observed in these cells. 
Due to the stable nature of IgB-ot when associated  with 
NF-KK inhibition of  protein synthesis has little effect on It,  B-or 
levels in unstimulated control cells. However, we found that 
IKB-c~ disappears in endotoxin-tolerant cells treated with CHX 
alone, which suggests that during endotoxin tolerance there 
is a continuous dissociation of  IgB-oL from the NF-xB subunits 
and a constant rate of de novo synthesis to replace the degraded 
protein. These observations indicate that the pathway leading 
to IKB-c~ phosphorylation and dissociation is intact in the 
endotoxin-tolerant  THP-1  cells,  and  that  the  endotoxin- 
tolerant phenotype may be partially due to enhanced rate of 
synthesis of IgB-ot  in  these cells. 
To date, no labile regulatory proteins have been identified 
for the other transcription factors that reguhte IL-lfl gene 
expression. However, it is becoming increasingly apparent 
that transcription factors from distinct families demonstrate 
physical and functional interactions that result in subunit and 
DNA binding site-specific enhancement or repression of tran- 
scription (28-30),  thus providing yet another level of com- 
plexity to  the regulation of eukaryotic gene expression. 
The ability of cells to adapt to continuous or repetitive 
stimulation is a general principle of cell biology (31). Adap- 
tation may directly involve control of receptor function, or 
altered intraceUular processes (32). Transcriptional  downregn- 
lation has been implicated in various adaptive processes,  in- 
cluding IFN-o~-induced desensitization of fibrobhsts  (33), 
antigen-dependent anergy to T cell IL-2 expression (34), and 
IL-4-induced downregulation of IL-2 expression (35).  Al- 
though labile regulatory factors were not investigated in the 
latter two systems, the involvement of a protein synthesis-de- 
pendent dominant repressor was reported in the former case. 
Our finding regarding regulation of endotoxin tolerance ex- 
tends the emerging importance of the role of dominant tran- 
scriptional repressors from the control of neoplasia and cell 
development to that of regulation of inflammation. This en- 
courages the speculation that synthesis of proteins that re- 
press transcription may prove to be a generalized mechanism 
by which many cell types regulate immunologic and inflam- 
matory anergic states. 
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